Navigating Risk, Treatment, and Reimbursement in Precision Oncology: Sadie Dobrozsi, MD
Published: | Updated:
Sadie Dobrozsi, MD, of Evolent, discusses how predictive genomics is pushing cancer care into a new era of personalization
Sadie Dobrozsi, MD, MS
Advertisement
Articles by Sadie Dobrozsi, MD, MS
Advertisement
Latest Updated Articles
Navigating Risk, Treatment, and Reimbursement in Precision Oncology: Sadie Dobrozsi, MDPublished: July 15th 2025 | Updated: July 15th 2025
Breast Cancer and the Use of Predictive GenomicsJune 18th 2025
Advertisement
Advertisement
Trending on AJMC
1
EHA 2026 Late Breakers Deliver Practice-Shifting Phase 3 Data and Novel CAR T Approaches Across Hematology
2
MRD-Guided CLL Treatment Duration: Personalization or Malpractice?
3
Teclistamab Outperforms Len/Dex in High-Risk Smoldering Myeloma With Higher CR Rate, PFS: Omar Nadeem, MD
4
Tec-Dara Demonstrates Superior 3-Year PFS vs Standard Therapy in Functional High-Risk Myeloma: Rahul Banerjee, MD
5